by admin | Oct 21, 2025 | News & Opinions
By Drug Target Review – USC researchers have engineered CAR T cells to deliver a dual protein therapy that targets solid tumours – offering hope for cancers previously resistant to treatment. Chimeric antigen receptor (CAR) T-cell therapy, which uses a patient’s...
by admin | Oct 20, 2025 | News & Opinions
by Tristan Manalac – BioSpace – Takeda is looking to offload its cell therapy platform and preclinical assets to a yet-unidentified external partner. 137 employees will be let go as part of the move. Takeda will no longer invest in cell therapies moving...
by admin | Oct 17, 2025 | News & Opinions
by Weill Cornell Medicine – he SCOPE system can capture proteins binding to regions of DNA that control gene expression. The illustration depicts part of the process where a small guide RNA delivers a protein bearing a special amino acid to the desired region....
by admin | Oct 16, 2025 | News & Opinions
By Science Daily – A Weill Cornell Medicine team has found that triple-negative breast cancer depends on the enzyme EZH2 to spread. By silencing key genes, EZH2 drives chaotic cell divisions and fuels metastasis. Blocking EZH2 restored stability and prevented...
by admin | Oct 15, 2025 | News & Opinions
by Technology Networks – In a first-in-human Phase 1/2a clinical trial, adult stem cells improved vision in patients with macular degeneration. In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who...
by admin | Oct 14, 2025 | News & Opinions
By Alison Satake – Mayo Clinic – More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the blood. Hemodialysis is a precursor to kidney transplant. To prepare for...
